Terns Pharmaceuticals Inc at H C Wainwright NASH Investor Conference (Virtual) Transcript
Hello, everyone. Welcome to the H.C. Wainwright Sixth Annual NASH Conference. For our next presentation, we have Justin Ng, the Director of Corporate Development of Terns Pharmaceuticals, a clinical-stage company developing treatments for NASH and other diseases as well. Justin, thank you very much for joining our presentation. Please go ahead.
Hi, Thomas. Thanks very much for the introduction and thanks to the H.C. Wainwright team for the opportunity to present at the conference today. I invite you all to go to our website to review our forward-looking statements at ternspharma.com. As a brief introduction to Terns, I wanted to highlight one of our core strengths, our people.
We have a highly seasoned management team that collectively has decades of experience in managing and financing biotechs as well as bring high-impact drugs to market. Numerous members of our management team have extensive shared work history at
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
